Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record Methodology

Covered recipient · General Payments record

AHMED HASSON

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1912646126
CMS profile
11917367
Location
SACRAMENTO, CA

General Payments · PY2025

$429.47

  • Reported across 17 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$429.47

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $429.47 17

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2025 $429.47 17

Payment records · PY2025 (17)

Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them

Program year 2025
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Ascendis Pharma Endocrinology Inc $29.03 11/04/2025 Food and Beverage Undisputed 06/30/2026 1237052334 CMS
Ascendis Pharma Endocrinology Inc $29.29 11/12/2025 Food and Beverage Undisputed 06/30/2026 1237052940 CMS
Bayer Healthcare Pharmaceuticals Inc. $25.82 09/25/2025 Food and Beverage Undisputed 06/30/2026 1225570059 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.95 11/25/2025 Food and Beverage Undisputed 06/30/2026 1223046418 CMS
GENZYME CORPORATION $21.25 11/17/2025 Food and Beverage Undisputed 06/30/2026 1233252625 CMS
Lilly USA, LLC $27.19 09/09/2025 Food and Beverage Undisputed 06/30/2026 1186489953 CMS
Lilly USA, LLC $26.92 10/07/2025 Food and Beverage Undisputed 06/30/2026 1186489843 CMS
Madrigal Pharmaceuticals $41.22 10/01/2025 Food and Beverage Undisputed 06/30/2026 1248268124 CMS
Madrigal Pharmaceuticals $31.86 12/16/2025 Food and Beverage Undisputed 06/30/2026 1248268126 CMS
Mannkind Corporation $24.10 11/20/2025 Food and Beverage Undisputed 06/30/2026 1250875714 CMS
Novartis Pharmaceuticals Corporation $23.65 12/02/2025 Food and Beverage Undisputed 06/30/2026 1200260389 CMS
Novartis Pharmaceuticals Corporation $29.44 12/18/2025 Food and Beverage Undisputed 06/30/2026 1200260391 CMS
Novo Nordisk Inc $25.93 10/13/2025 Food and Beverage Undisputed 06/30/2026 1188336220 CMS
Novo Nordisk Inc $26.99 11/08/2025 Food and Beverage Undisputed 06/30/2026 1188258632 CMS
Tandem Diabetes Care, Inc. $2.17 10/28/2025 Food and Beverage Undisputed 06/30/2026 1241268417 CMS
Tandem Diabetes Care, Inc. $27.06 10/28/2025 Food and Beverage Undisputed 06/30/2026 1241268421 CMS
Tandem Diabetes Care, Inc. $12.60 12/16/2025 Food and Beverage Undisputed 06/30/2026 1241268413 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2025
Source files
Dataset page · Bulk file · PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.